Robert A Horlick

This inventor holds 15 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Anaptysbio, Inc., Lassen Therapeutics, Inc., Lassen Therapeutics 1, Inc.. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert A Horlick. Retrieved from https://idiyas.com/inventor/robert-a-horlick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 11)

% Patents Active = 93.3

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 22(Granted Patents)

Company Filing History:

Lassen Therapeutics, Inc.

patents

1 out of 1

Lassen Therapeutics 1, Inc.

patent

4. 1 out of 1

Pharmacopeia Drug Disclovery, Inc.

patent

5. 1 out of 52

Pharmacopeia Drug Discovery, Inc.

patents

Years Active: 2006-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12365738 - Method of treating an interleukin-11-associated or -mediated fibrotic disease or condition by administering an anti-interleukin-11 receptor subunit alpha (IL-11RA) antibody (2025-07-22),

2. 12365737 - Anti-IL-18BP antibodies (2025-07-22),

3. 12129303 - Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies (2024-10-29),

4. 11999783 - Method of treating autoimmune disease with antibodies against IL-33 (2024-06-04),

5. 10836820 - Method of treating inflammatory disorder with antibodies directed against interleukin-33 (IL-33) (2020-11-17),

6. 10059764 - Antibodies directed against interleukin-33 (IL-33) and methods of making and using (2018-08-28),

7. 9951126 - Antibodies directed against nerve growth factor (NGF) (2018-04-24),

8. 9637556 - Methods of generating libraries and uses thereof (2017-05-02),

9. 9328166 - Antibodies directed against IL-17 (2016-05-03),

10. 9260533 - Methods of generating libraries and uses thereof (2016-02-16),

11. 8926978 - Antibodies directed against nerve growth factor (NGF) (2015-01-06),

12. 8685897 - Methods of generating libraries and uses thereof (2014-04-01),

13. 8603950 - Methods of generating libraries and uses thereof (2013-12-10),

14. 7084154 - 2-(aminomethyl) arylamide analgesics (2006-08-01),

15. 7041463 - Orthologues of human receptors and methods of use (2006-05-09),

Title: Robert A. Horlick - Innovator from San Diego

Introduction: Robert A. Horlick is a renowned inventor based in San Diego, California, known for his groundbreaking contributions to various industries.

Latest Patents: Robert A. Horlick holds several patents in the fields of renewable energy, sustainable technologies, and medical devices, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Robert has established himself as a visionary inventor, with a keen focus on developing solutions that positively impact society and the environment.

Collaborations: Throughout his career, Robert A. Horlick has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and progress.

Conclusion: Robert A. Horlick's passion for innovation and his relentless drive to create meaningful change make him a standout figure in the world of inventors, with his work continuing to inspire future generations of innovators.

Profile summary based on public USPTO records.